Case details

Court: ded
Docket #: 1:16-cv-00554
Case Name: Janssen Pharmaceutica N.V. v. Xellia Pharmaceuticals ApS
PACER case #: 59751
Date filed: 2016-06-29
Date terminated: 2016-12-22
Assigned to: Judge Leonard P. Stark
Case Cause: 35:271 Patent Infringement
Nature of Suit: 830 Patent
Jury Demand: None
Jurisdiction: Federal Question

Parties

Represented Party Attorney & Contact Info
Janssen Pharmaceutica N.V.
Plaintiff
 
Jack B. Blumenfeld
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street
P.O. Box 1347
Wilmington, DE 19899
(302) 658-9200
Email: jbbefiling@mnat.com
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Brian P. Egan
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street
P.O. Box 1347
Wilmington, DE 19899
302-351-9454
Email: began@mnat.com
ATTORNEY TO BE NOTICED
Xellia Pharmaceuticals ApS
Defendant

Documents

Date Filed Document # Attachment # Short Description Long Description Upload date SHA1 hash
2016-06-29 1 0 COMPLAINT filed against Xellia Pharmaceuticals ApS - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1956293.) - filed by Janssen Pharmaceutica N.V.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(sar) (Entered: 06/30/2016)
2016-06-29 2 0 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) (Entered: 06/30/2016)
2016-06-29 3 0 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/24/2016. Date of Expiration of Patent: 6/18/2019.Thirty Month Stay Deadline: 11/24/2018. (sar) (Entered: 06/30/2016)
2016-06-29 4 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,407,079 B1;. (sar) (Entered: 06/30/2016)
2016-06-29 5 0 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceutica N.V. filed by Janssen Pharmaceutica N.V.. (sar) (Entered: 06/30/2016)
2016-07-01 6 0 MOTION for Pro Hac Vice Appearance of Attorney Elizabeth Stotland Weiswasser and Audrey Maness - filed by Janssen Pharmaceutica N.V.. (Egan, Brian) (Entered: 07/01/2016)
2016-09-27 7 0 SUMMONS Returned Executed by Janssen Pharmaceutica N.V.. Xellia Pharmaceuticals ApS served on 9/27/2016, answer due 10/18/2016. (Blumenfeld, Jack) (Entered: 09/27/2016)
2016-09-28 8 0 STIPULATION TO EXTEND TIME for defendant to move, answer, or otherwise respond to the Complaint to December 19, 2016 - filed by Janssen Pharmaceutica N.V.. (Blumenfeld, Jack) (Entered: 09/28/2016)
2016-12-13 9 0 PROPOSED CONSENT JUDGMENT by Janssen Pharmaceutica N.V.. (Blumenfeld, Jack) (Entered: 12/13/2016)
2016-12-22 10 0 CONSENT JUDGMENT, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 12/22/16. (ntl) (Entered: 12/22/2016)
2016-12-27 11 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number 6,407,079. (etg) (Entered: 12/27/2016)